Skip to content

Drug interactions

Brentuximab vedotin + Imatinib

Severity: Moderate

Brentuximab vedotin and Imatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib is a moderate CYP3A4 inhibitor and may raise exposure to MMAE released from brentuximab vedotin. This could worsen neutropenia and neuropathy.

What this interaction means in plain words

Brentuximab vedotin and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brentuximab vedotin belongs to Oncology; Imatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 by imatinib reduces MMAE clearance.

What to do

Monitor blood counts and neuropathy symptoms, and consider dose delay for neutropenia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab vedotin and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab vedotin with Imatinib?

MediHelp rates the interaction as moderate. Brentuximab vedotin and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib is a moderate CYP3A4 inhibitor and may raise exposure to MMAE released from brentuximab vedotin. This could worsen neutropenia and neuropathy.

How serious is the interaction between Brentuximab vedotin and Imatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and neuropathy symptoms, and consider dose delay for neutropenia.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in